E-book
The power of using integrated data to understand drug performance
These real-world examples show how integrated data can help you improve medication adherence, track patient journeys, evaluate total cost of care and more.
Dig deeper into the evolving role of real-world evidence
Clinicogenomics linked data advances research
Clinicogenomics data can fuel all stages of development.
Four steps to an enterprise data strategy
Maximize data investments.
Is Your Real-World Data Research Ready?
Go behind the scenes of real-world data.
Insights
Assisting the FDA with real-world evidence
As seen in Frost & Sullivan's Movers & Shakers series
The 11 things life sciences leaders need to know
We identified 11 trends worth watching.
Accelerate drug development with clinicogenomic RWE
Optum, Novartis and GuardantINFORM experts discuss the ever-increasing importance of clinicogenomic data during this Endpoints News webinar.
Watch: OLS Data Leaders at STAT Summit
Break down common missteps when using RWD and create practical strategies to overcome them.
PMSA Webinar: Avoiding common RWD pitfalls
Optum experts give a snapshot of commonly encountered pitfalls when using RWD and recommendations to help avoid them in this PMSA webinar.
Sleep treatment across the ages
Combining real-world data and primary research helps us better understand insomnia.
Optum Dynamic Assessment of Pregnancies and Infants
Assess the impact of medication use during pregnancy and the impact on infant health.
Optum, FDA collaborate on vaccine and biologic research
FDA reaches agreement with life sciences segment of Optum to provide data and expertise to evaluate and research biologics and vaccines.
Real-world data fills rare disease data gaps
Data removes the barriers to understanding rare disease.
Evolving clinical trials from paper to digital
Accelerate research through a digitized model.
Dynamic Assessment Of Pregnancies And Infants
We help answer questions about maternal and infant health.
The unifying power of integrated data
Read how the integration of EHR and claims data can change what we can collectively learn about outcomes.
Curious case of costly complications
How can analytics help tell your cost and outcomes story?
Clinicogenomics: The next big leap in real-world data
Optum clinical genomics is positioned to shape a new generation of evidence that accelerates understanding of disease.
Realizing the full potential of clinicogenomics
Join Optum genomics experts as they discuss the progress being made to develop datasets that will aid in drug discovery and development.
The Curious Case of the Costly Complication
Optum helps a client prove product effectiveness
Clinicogenomics: new, linked data is advancing research
Rich, longitudinal clinicogenomics data can fuel all stages of drug development.
Modernizing clinical trials with EHRs
Discover how Optum and three provider organizations leveraged EHR systems to modernize a clinical trial aimed at diabetes treatment.
Optum Patient Profiles For Life Sciences Video
A more complete view of the patient experience
Maximize Clinical Trial Enrollment
Use clinical and claims data to conduct precision patient finding.
Forward-thinking strategies for 2022
Explore this video series featuring insights for Life Sciences leaders, delivered by experts from across health care.
Monitoring COVID-19 vaccine safety
Discover insights from Dr. John Seeger’s recent participation at the Duke-Margolis Thirteenth Annual Sentinel Initiative Public Workshop.
Pinpoint asthma, COPD and ACOS with EHR data
Optum study highlights clinical clues in asthma and COPD.
Real-world data centralized teams
Expanding the use of RWD requires expertise and leadership.
When ‘Is it safe for me?’ changes to ‘Is it safe for us?’
Studying the impact of treatments on pregnancy and infants can help patients, providers and pharmaceutical companies make key decisions.
Four steps to a RWD enterprise strategy
Lou Brooks, SVP, Real-World Data and Analytics at Optum
Real Talk on Real-World Evidence: Practical Applications in 2021
Virtual fireside chat with Advisory Board and Optum Life Sciences leaders explores the expanded use and next wave of RWE applications
New Data Dimensions In Life Sciences Research
Expanded research methods can address cost at the root level.
Preparing for the future of life sciences
Life sciences leaders are thinking differently with data to support novel strategies.
Demonstrating product value with integrated data
A special webinar hosted by MM&M demonstrates how integrated EHR and claims data offers a new foundation for demonstrating product value.
Four steps to an enterprise data strategy
Explore the steps for creating a real-world data strategy that helps life sciences companies to maximize their data investments.
Is Your Real-World Data Research Ready?
Real-world data can help evaluate the effectiveness of medications and therapies, which is why evaluation should be part of the investment.
Clinicogenomics Enable Precision Drug Development | Optum
Building public confidence with health data
See how the FDA and Optum use real-world evidence to monitor the safety and effectiveness of COVID-19 vaccines in our youngest populations.
7 Trends Shaping Life Sciences Strategies in 2023
Life sciences market experts from Optum and Advisory Board offer their bold predictions and insights in 2023 for the industry.
Informing the FDA BEST Initiative
As a key FDA collaborator, Optum Epidemiology generates reproducible results that inform regulatory decisions for COVID-19 vaccines.
Pilot Program Lowers Cardiovascular Disease Risk
An innovative program involving patient awareness and provider outreach improves patient use of lipid-lowering therapies.
Reconcile your RWD expectations to maximize your investment
Understand how routine clinical practice impacts information captured in real-world data (RWD).
RWD Pitfalls Part 1: Using the right tools to approach RWD
When working with real-world data, learn from the lessons of others to help maximize your own business return.
Meet with our experts at ISPOR 2023
Missing pieces in the patient journey puzzle
Clinicogenomic data, unstructured data and novel clinical trials solutions can all contribute to completing the view of the patient journey.
Life Sciences: Top stakeholder questions to consider
Ask your stakeholders what they need early on. Consider these top questions that patients, providers, payers and regulators are looking to answer.
Reassess the Inflation Reduction Act with evidence in mind
Cut through the noise of the Inflation Reduction Act of 2022 with key points aimed to help life sciences leaders leverage impactful data.
Improving SGLT2i Therapy Adherence for Patients [Case Study]
Article that covers OLS and Boehringer Ingelheim collaboration to increase adherence for patients with diabetes and CVD.
Novel data collection for a difficult-to-study condition
To build a more complete picture of the patient burden, the Optum HEOR team investigates patients’ experiences with their treatment journey.
Reflections on PCMA's recent Annual Meeting
Total cost of care and value-based arrangements between manufacturers and payers is top of mind of HEOR and Medical Affairs leaders.
Are You Maximizing the ROI of Your Real-World Data?
Help your organization capitalize on these vital resources using lessons and tools compiled by the Optum life sciences real-world data team.
Top